Psyence Biomedical Ltd.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Psyence Biomedical Ltd.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
—
No changes.
No changes.
Annual filing, covered
20-F parsed · Jun 22 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
20-F parsed · Jun 22 '26
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
—
Expected move
No implied move.
Psyence Biomedical Ltd.
3.33
+0.15 · +4.71%
post 3.13 −6.00%
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Psyence Biomedical Ltd..
Same SIC code · 6
Same SEC industry code: ELI Lilly & Co, Johnson & Johnson, AbbVie Inc. and 3 more; no measured co-movers for Psyence Biomedical Ltd..
| Manager | Value | % base | |
|---|---|---|---|
| Parallel | $463,000 | 41.04% | 0.00% |
| AdvisorShares | $373,883 | 33.14% | new |
| Morgan Stanley | $115,680 | 10.25% | new |
| Jane Street | $93,119 | 8.25% | new |
| XTX Topco | $46,188 | 4.09% | new |
| Manager | Value | % base | |
|---|---|---|---|
| Parallel | $463,000 | 41.04% | 0.00% |
| AdvisorShares | $373,883 | 33.14% | new |
| Morgan Stanley | $115,680 | 10.25% | new |
| Jane Street | $93,119 | 8.25% | new |
| XTX Topco | $46,188 | 4.09% | new |
—
Largest filed tie
—
—
—